Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.
Cancer Lett
; 381(1): 76-84, 2016 10 10.
Article
in En
| MEDLINE
| ID: mdl-27475932
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinazolines
/
Breast Neoplasms
/
Receptor, ErbB-2
/
Drug Resistance, Neoplasm
/
Protein Kinase Inhibitors
/
Benzodioxoles
/
Quinazolinones
/
Mammary Neoplasms, Experimental
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cancer Lett
Year:
2016
Document type:
Article
Affiliation country:
Italy
Country of publication:
Ireland